DUBLIN, IRELAND--(Marketwire - October 08, 2007) - Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today notifies the Irish Stock Exchange of its decision to delist from the Irish Stock Exchange.
